Cassava Sciences Inc (NASDAQ:SAVA) shares, rose in value on Wednesday, March 26, with the stock price down by -7.89% to the previous day’s close as strong demand from buyers drove the stock to $1.75.
Actively observing the price movement in the last trading, the stock closed the session at $1.90, falling within a range of $1.74 and $2.01. The value of beta (5-year monthly) was -1.24. Referring to stock’s 52-week performance, its high was $42.20, and the low was $1.80. On the whole, SAVA has fluctuated by -27.69% over the past month.
With the market capitalization of Cassava Sciences Inc currently standing at about $84.54 million, investors are eagerly awaiting this quarter’s results, scheduled for on 2025-Mar-02.
Technical indicators serve as essential tools for traders, offering insights into market sentiment and potential price movements. We see that SAVA’s technical picture suggests that short-term indicators denote the stock is a 50% Sell on average. However, medium-term indicators have put the stock in the category of 100% Sell while long-term indicators on average have been pointing out that it is a 100% Sell.
The stock’s technical analysis shows that the price of SAVA currently trading nearly -33.04% and -30.87% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 28.42, while the 7-day volatility ratio is showing 12.18% which for the 30-day chart, stands at 9.28%. Furthermore, Cassava Sciences Inc (SAVA)’s beta value is -1.67, and its average true range (ATR) is 0.26.
A comparison of Cassava Sciences Inc (SAVA) with its peers suggests the former has fared considerably weaker in the market. SAVA showed an intraday change of -7.89% in last session, and over the past year, it shrunk by -91.17%%.
Data on historical trading for Cassava Sciences Inc (NASDAQ:SAVA) indicates that the trading volumes over the past 10 days have averaged 2.65 and over the past 3 months, they’ve averaged 2.20 million. According to company’s latest data on outstanding shares, there are 48.20 million shares outstanding.
Nearly 13.11% of Cassava Sciences Inc’s shares belong to company insiders and institutional investors own 36.19% of the company’s shares. The data on short interest also indicates that stock shorts accounted for 11.88 million shares as on 2025-03-14, resulting in a short ratio of 7.09. According to the data, the short interest in Cassava Sciences Inc (SAVA) stood at 2623.00 of shares outstanding as of 2025-03-14; the number of short shares registered in 2025-02-14 reached 15.94 million. The stock has fallen by -25.85% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the SAVA stock heading into the next quarter.
